Holen Sie sich die Stockscreener-App
26.37
6.02%
-1.69
Handel nachbörslich:
26.37
Schlusskurs vom Vortag:
$28.06
Offen:
$28.22
24-Stunden-Volumen:
1.38M
Relative Volume:
1.03
Marktkapitalisierung:
$1.79B
Einnahmen:
$2.74B
Nettoeinkommen (Verlust:
$-441.40M
KGV:
-4.0321
EPS:
-6.54
Netto-Cashflow:
$13.00M
1W Leistung:
-12.04%
1M Leistung:
-4.56%
6M Leistung:
-0.19%
1J Leistung:
-37.17%
1-Tages-Spanne:
$26.34
$28.53
1-Wochen-Bereich:
$26.34
$30.49
52-Wochen-Spanne:
$22.05
$49.45
Quidelortho Corporation Stock (QDEL) Company Profile
Firmenname
Quidelortho Corporation
Sektor
Branche
Telefon
(858) 552-1100
Adresse
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Vergleichen Sie QDEL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
26.37 | 1.91B | 2.74B | -441.40M | 13.00M | -6.54 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-09-19 | Fortgesetzt | UBS | Neutral |
| 2024-09-05 | Hochstufung | Craig Hallum | Hold → Buy |
| 2024-03-04 | Herabstufung | UBS | Neutral → Sell |
| 2024-02-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-14 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-19 | Eingeleitet | Citigroup | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Sell |
| 2022-06-17 | Fortgesetzt | JP Morgan | Neutral |
| 2022-02-22 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-03-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Bestätigt | Barclays | Overweight |
| 2018-01-04 | Hochstufung | CL King | Neutral → Buy |
| 2017-09-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Bestätigt | Canaccord Genuity | Hold |
| 2017-02-17 | Eingeleitet | CL King | Neutral |
| 2016-12-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Bestätigt | Barclays | Overweight |
| 2016-02-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-12-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Eingeleitet | Barclays | Overweight |
| 2013-07-31 | Bestätigt | Canaccord Genuity | Buy |
| 2011-03-03 | Herabstufung | Wedbush | Outperform → Neutral |
Alle ansehen
Quidelortho Corporation Aktie (QDEL) Neueste Nachrichten
What’s the recovery path for long term holders of QuidelOrtho Corporation2025 Trading Recap & Weekly Watchlist for Hot Stocks - newser.com
Using fundamentals and technicals on QuidelOrtho CorporationTreasury Yields & Fast Moving Stock Trade Plans - newser.com
How QuidelOrtho Corporation stock trades during market volatilityEarnings Beat & Low Drawdown Investment Strategies - newser.com
Visualizing QuidelOrtho Corporation stock with heatmaps2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Backtesting results for QuidelOrtho Corporation trading strategiesStop Loss & Capital Efficient Trade Techniques - newser.com
QuidelOrtho (QDEL): Exploring Valuation After Analyst Downgrade and Weaker Growth Outlook - Yahoo
Is QuidelOrtho Corporation QL1A a good long term investmentHigh Yield Income Stocks & Start Small. End Wealthy. - earlytimes.in
Gagnon Securities LLC Has $2.10 Million Stock Holdings in QuidelOrtho Corporation $QDEL - MarketBeat
QuidelOrtho Corp. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
QuidelOrtho (NASDAQ:QDEL) Shares Gap DownHere's What Happened - MarketBeat
Why QuidelOrtho (QDEL) Stock Is Down Today - TradingView
Citigroup Downgrades QuidelOrtho to Neutral From Buy, Adjusts Price Target to $33 From $40 - MarketScreener
Exploring QuidelOrtho (QDEL) Valuation as Shares Decline 6% to Close at $29.98 - simplywall.st
What sentiment indicators say about QuidelOrtho Corporation stockLong Setup & Technical Entry and Exit Alerts - newser.com
Why QuidelOrtho Corporation (QL1A) stock could be next leaderWeekly Gains Summary & High Win Rate Trade Alerts - newser.com
Will QuidelOrtho Corporation (QL1A) stock keep raising dividends2025 Market Trends & Detailed Earnings Play Alerts - newser.com
Will QuidelOrtho Corporation continue its uptrend2025 Market WrapUp & Precise Buy Zone Identification - newser.com
Does QuidelOrtho Corporation show high probability of reboundChart Signals & Free Fast Gain Swing Trade Alerts - newser.com
How QuidelOrtho Corporation (QL1A) stock behaves under inflation pressureTrade Performance Summary & Community Verified Watchlist Alerts - newser.com
Long term hold vs stop loss in QuidelOrtho CorporationMarket Activity Recap & AI Optimized Trade Strategies - newser.com
Will QuidelOrtho Corporation bounce back from current supportWeekly Trade Report & Weekly Breakout Opportunity Watchlist - newser.com
Will QuidelOrtho’s (QDEL) Rapid Respiratory Test Raise Its Profile in Point-of-Care Diagnostics? - simplywall.st
QuidelOrtho (NASDAQ:QDEL) Trading Down 5.5%What's Next? - MarketBeat
Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know - TradingView
QuidelOrtho launches QUICKVUE Influenza + SARS Test - SelectScience
QuidelOrtho Corporation (NASDAQ:QDEL) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
QuidelOrtho Corp. Hits Day High with Strong 10.99% Intraday Surge - Markets Mojo
How to forecast QuidelOrtho Corporation trends using time seriesM&A Rumor & Consistent Growth Stock Picks - newser.com
QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test - Yahoo Finance
Finanzdaten der Quidelortho Corporation-Aktie (QDEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):